<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36961039</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2226-4787</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>22</Day></PubDate></JournalIssue><Title>Pharmacy (Basel, Switzerland)</Title><ISOAbbreviation>Pharmacy (Basel)</ISOAbbreviation></Journal><ArticleTitle>SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">61</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pharmacy11020061</ELocationID><Abstract><AbstractText>This study aims to demonstrate the improvements in clinical symptoms in patients with post-COVID syndrome after a community pharmacy-based intervention in Serbia. The Pharmaceutical Chamber of Serbia ("Chamber") invited pharmacists to deliver post-COVID patient care counselling, supported by the SMART Pharmacist Program, offering education and guidance. Present symptoms, duration and patient self-reported severity of symptoms on a scale of 1-5 on the first visit were recorded. After the counselling and proposed self-medication treatment, the time of the follow-up visit and the severity of the recorded symptoms were also recorded. The prospective data collection lasted from December 2021 to September 2022. In total, 871 patients with post-COVID symptoms were included in the study, served by 53 pharmacists. The most frequently reported post-COVID symptoms coincided with the literature, mostly related to the respiratory system (51.2%), immunity status (32.2%), fatigue and exhaustion (30.7%), skin, hair and nails (27.4%) and cognitive functions (27.9%). A total of 26.5% of patients were referred to their family physician (general practitioner), and 69.5% returned to the pharmacist for a follow-up visit. On the first visit, the median severity of patients' symptoms was three, while on the second visit it dropped to one. The pharmacists' intervention led to a significant improvement in the post-COVID patients' condition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#x160;ipeti&#x107;</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>AU Lilly Drogerie, Patrijarha Dimitrija 14, 11090 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Pharmaceutical Chamber of Serbia, Mutapova 25, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajkovi&#x107;</LastName><ForeName>Dragana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Pharmaceutical Chamber of Serbia, Mutapova 25, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogavac Stanojevi&#x107;</LastName><ForeName>Nata&#x161;a</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinkovi&#x107;</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-6745-5059</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Me&#x161;trovi&#x107;</LastName><ForeName>Arijana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9207-0027</Identifier><AffiliationInfo><Affiliation>Pharma Expert Consultancy and Education, De&#x161;&#x10d;evec 56, 10040 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouse</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-0640-9184</Identifier><AffiliationInfo><Affiliation>International Services Program, Accreditation Council for Pharmacy Education (ACPE), Chicago, IL 60603, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmacy (Basel)</MedlineTA><NlmUniqueID>101678532</NlmUniqueID><ISSNLinking>2226-4787</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SMART pharmacist</Keyword><Keyword MajorTopicYN="N">community pharmacy-based intervention</Keyword><Keyword MajorTopicYN="N">continuing professional development</Keyword><Keyword MajorTopicYN="N">follow-up visit</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID symptoms</Keyword><Keyword MajorTopicYN="N">self-medication</Keyword><Keyword MajorTopicYN="N">severity of symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>8</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36961039</ArticleId><ArticleId IdType="pmc">PMC10037608</ArticleId><ArticleId IdType="doi">10.3390/pharmacy11020061</ArticleId><ArticleId IdType="pii">pharmacy11020061</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Institute for Public Health &#x201c;Dr Milan Jovanovic Batut&#x201d;.  [(accessed on 13 December 2022)].  Available online:  https://covid19.rs/homepage-english/</Citation></Reference><Reference><Citation>WHO Regional Office for Europe.  [(accessed on 13 December 2022)].  Available online:  https://covid19.who.int/region/euro/country/rs.</Citation></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Qu C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy S., Gomersall C.D., Fowler R.A. Care for Critically Ill Patients With COVID-19. JAMA. 2020;323:1499&#x2013;1500. doi: 10.1001/jama.2020.3633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3633</ArticleId><ArticleId IdType="pubmed">32159735</ArticleId></ArticleIdList></Reference><Reference><Citation>Olufemi E. The Lancet Global Health. Volume 10. Elsevier; Amsterdam, The Netherlands: 2013. Post-COVID-19 condition: Current evidence and unanswered questions; pp. e1210&#x2013;e1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363039</ArticleId><ArticleId IdType="pubmed">35961329</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP)  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 13 December 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. (9 July 2021). Post-COVID conditions: Information for healthcare providers.  [(accessed on 13 December 2022)]; Available online:  www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute COVID-19 in primary care.  [(accessed on 20 January 2023)];BMJ. 2020 370:m3026. doi: 10.1136/bmj.m3026. Available online:  https://www.bmj.com/content/370/bmj.m3026.full.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance.  [(accessed on 22 September 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html#management.</Citation></Reference><Reference><Citation>Good Pharmacy Practice Guideline &#x201c;Official Gazette of Republic of Serbia&#x201d; 27, 2021)  [(accessed on 20 January 2023)].  Available online:  https://www.farmkom.rs/farmkom.php?id=69.</Citation></Reference><Reference><Citation>Rouse M.J., Mestrovi&#x107; A. Learn Today-Apply Tomorrow: The SMART Pharmacist Program. Pharmacy. 2020;8:139. doi: 10.3390/pharmacy8030139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmacy8030139</ArticleId><ArticleId IdType="pmc">PMC7557602</ArticleId><ArticleId IdType="pubmed">32781775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group Post-COVID-19 global health strategies: The need for an interdisciplinary approach. Aging Clin. Exp. Res. 2020;32:1613&#x2013;1620. doi: 10.1007/s40520-020-01616-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Doing What Matters in Times of Stress.  [(accessed on 20 January 2023)].  Available online:  https://www.who.int/publications/i/item/9789240003927.</Citation></Reference><Reference><Citation>World Health Organization . Support for Rehabilitation: Self-Management after COVID-19-Related Illness. World Health Organization, Regional Office for Europe; Geneva, Switzerland: 2021. No. WHO/EURO: 2021-855-40590-59892.</Citation></Reference><Reference><Citation>Guidelines for Pharmacists in Primary Health Care; The Pharmaceutical Chamber of Serbia, The Faculty of Pharmacy, University of Belgrade and The Union of Pharmaceutical Associations of Serbia, 2021.  [(accessed on 20 February 2023)]; Available online:  https://www.zdravlje.gov.rs/view_file.php?file_id=2268&amp;cache=sr.</Citation></Reference><Reference><Citation>Almas T., Malik J., Alsubai A.K., Zaidi S.M.J., Iqbal R., Khan K., Ali M., Ishaq U., Alsufyani M., Hadeed S., et al. Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review. Ann. Med. Surg. 2022;80:103995. doi: 10.1016/j.amsu.2022.103995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103995</ArticleId><ArticleId IdType="pmc">PMC9197790</ArticleId><ArticleId IdType="pubmed">35721785</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Workman C.D., Bryant A.D. Potential Factors That Contribute to Post-COVID-19 Fatigue in Women. Brain Sci. 2022;12:556. doi: 10.3390/brainsci12050556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12050556</ArticleId><ArticleId IdType="pmc">PMC9139370</ArticleId><ArticleId IdType="pubmed">35624943</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortajada C., Navarro A., Andreu-Ballester J.C., Mayor A., A&#xf1;&#xf3;n S., Flores J. Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge. Intern. Emerg. Med. 2022;17:929&#x2013;934. doi: 10.1007/s11739-021-02895-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02895-6</ArticleId><ArticleId IdType="pmc">PMC8754532</ArticleId><ArticleId IdType="pubmed">35023003</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized patients: A population-based study. Int. J. Environ. Res. Public Health. 2021;18:2030. doi: 10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042030</ArticleId><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Helman S.N., Adler J., Jafari A., Bennett S., Vuncannon J.R., Cozart A.C., Wise S.K., Kuruvilla M.E., Levy J.M. Treatment strategies for postviral olfactory dysfunction: A systematic review. Allergy. Asthma. Proc. 2022;43:96&#x2013;105. doi: 10.2500/aap.2022.43.210107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2022.43.210107</ArticleId><ArticleId IdType="pmc">PMC8984764</ArticleId><ArticleId IdType="pubmed">35317886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharaba Z., Moutraji S.A., Khawaldeh R.A.A., Alfoteih Y., Meslamani A.Z.A. What has changed in the pharmaceutical care after COVID-19: Pharmacists&#x2019; perspective. Pharm. Pract. 2022;20:2656. doi: 10.18549/PharmPract.2022.2.2656.</Citation><ArticleIdList><ArticleId IdType="doi">10.18549/PharmPract.2022.2.2656</ArticleId><ArticleId IdType="pmc">PMC9296094</ArticleId><ArticleId IdType="pubmed">35919794</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan D., Guiu-Segura J.M., Sousa-Pinto G., Wang L.N. How COVID-19 has impacted the role of pharmacists around the world. Farm. Hosp. 2021;45:89&#x2013;95. doi: 10.7399/fh.11652.</Citation><ArticleIdList><ArticleId IdType="doi">10.7399/fh.11652</ArticleId><ArticleId IdType="pubmed">33709893</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R., Riste L., Hann M., Walther A., Mukherjee A., Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med. Hypotheses. 2020;144:110055. doi: 10.1016/j.mehy.2020.110055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>International Pharmaceutical Federation  FIP Statement of Policy-Pharmacy: Gateway to Care. The Hague: FIP, 2017.  [(accessed on 20 January 2023)].  Available online:  https://www.fip.org/statements.</Citation></Reference><Reference><Citation>Popescu M.N., Berteanu M., Beiu C., Popa L.G., Mihai M.M., Iliescu M.G., St&#x103;nescu A.M.A., Ionescu A.M. Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium. Clin. Cosmet. Investig. Dermatol. 2022;15:735&#x2013;743. doi: 10.2147/CCID.S359052.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CCID.S359052</ArticleId><ArticleId IdType="pmc">PMC9042074</ArticleId><ArticleId IdType="pubmed">35497690</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCallum L., Dolovich L. Follow-up in community pharmacy should be routine, not extraordinary. Can. Pharm. J. 2018;151:79&#x2013;81. doi: 10.1177/1715163518756586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1715163518756586</ArticleId><ArticleId IdType="pmc">PMC5843118</ArticleId><ArticleId IdType="pubmed">29531619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestrovic A., Rouse M.J. Pillars and foundations of quality for continuing education in pharmacy. Am. J. Pharm. Educ. 2015;79:45. doi: 10.5688/ajpe79345.</Citation><ArticleIdList><ArticleId IdType="doi">10.5688/ajpe79345</ArticleId><ArticleId IdType="pmc">PMC4428430</ArticleId><ArticleId IdType="pubmed">25995520</ArticleId></ArticleIdList></Reference><Reference><Citation>International Pharmaceutical Federation. Quality Assurance of Pharmacy Education: The FIP Global Framework. 2014.  [(accessed on 25 January 2023)].  Available online:  https://www.fip.org/files/fip/PharmacyEducation/Quality_Assurance/QA_Framework_2nd_Edition_online_version.pdf.</Citation></Reference><Reference><Citation>Apikoglu S., Selcuk A., Ozcan V., Balta E., Turker M., Albayrak O.D., Mestrovic A., Rouse M., Uney A. Author Correction to: The first nationwide implementation of pharmaceutical care practices through a continuing professional development approach for community pharmacists. Int. J. Clin. Pharm. 2023;45:281&#x2013;282. doi: 10.1007/s11096-022-01512-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-022-01512-6</ArticleId><ArticleId IdType="pmc">PMC10074512</ArticleId><ArticleId IdType="pubmed">36342566</ArticleId></ArticleIdList></Reference><Reference><Citation>Korff M., Jensen M.P., Karoly P. Assessing global pain severity by self-report in clinical and health services research. Spine. 2000;25:3140&#x2013;3151. doi: 10.1097/00007632-200012150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200012150-00009</ArticleId><ArticleId IdType="pubmed">11124730</ArticleId></ArticleIdList></Reference><Reference><Citation>Haefeli M., Elfering A. Pain assessment. Eur. Spine J. 2006;15((Suppl. S1)):S17&#x2013;S24. doi: 10.1007/s00586-005-1044-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-005-1044-x</ArticleId><ArticleId IdType="pmc">PMC3454549</ArticleId><ArticleId IdType="pubmed">16320034</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>